Research Studies » Monoclonal Antibody Treatment for COVID-19

Adapt Out COVID is a master protocol to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with COVID-19. A larger phase III evaluation for promising agents (Monoclonal Antibody)
Powered By RealTime-CTMS Clinical Trial Management System